Genetic Technologies Ltd (GENE)

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2

MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic...

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform

CHARLOTTE, N.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15

MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”),...

Genetic Technologies Strategic Restructure Driving USA Sales Growth

CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in...

GeneType to Enter Canadian and New Zealand Markets

Genomics-based testing brand expands international presence as pilot influencer campaign fuels sales

GeneType to Enter Canadian and New Zealand Markets

GeneType to Enter Canadian and New Zealand Markets...

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Results from commercial sales of predictive testing across the US and Australia establish clear advantages of geneType Risk Assessment Tests for a more preventive approach in disease management

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease...

Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27

Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27

Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27...